SCHEMBL2320928

SCHEMBL2320928

O=C1CCCc2c1n(C(=O)O)c1cc(Cl)c(F)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
CREBBP Q92793 1/20 0.43
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
HPGD P15428 4/20 0.41
MAPT P10636 4/20 0.41
MAPK1 P28482 3/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.33
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
AR P10275 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2365506 0.89 TP53 (0.47) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL22529386 0.87 TP53 (0.44) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL2359949 0.83 TP53 (0.40) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL2360304 0.81 TP53 (0.40) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL2360526 0.77 TP53 (0.43) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL20602027 0.74 TP53 (0.51) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL20602023 0.74 TP53 (0.51) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL2360606 0.72 TP53 (0.43) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL14688848 0.71 TP53 (0.42) TP53CREBBPKDM4EALDH1A1HSD17B10
SCHEMBL14688661 0.70 KDM4E (0.46) TP53KDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121285-A1 Selective androgen receptor modulators RADIUS HEALTH INC (US) 2017-05-04 US disclosed
EP-2531029-B1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2016-10-19 EP disclosed
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2015-09-24 US disclosed
US-8987319-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2015-03-24 US disclosed
US-20130041007-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. 2013-02-14 US disclosed
EP-2531029-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS Radius Health, Inc. (US) 2012-12-12 EP disclosed
WO-2011097496-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH, INC. (US) 2011-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121285-A1 Selective androgen receptor modulators AR, SHBG, FSHR TP53 1244/4885CREBBP 2874/4885KDM4E 1228/4885
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS AR, SHBG, FSHR TP53 1247/4885CREBBP 2880/4885KDM4E 1235/4885
US-20130041007-A1 Selective Androgen Receptor Modulators AR, SHBG, GPR119 TP53 1188/4885CREBBP 2943/4885KDM4E 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.